| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097598 Method of treating neurological disorders using acetone derivatives |
| 05/20/2004 | US20040097597 Reducing side effects while elevating serum testosterone levels; having higher trans to cis ratio |
| 05/20/2004 | US20040097592 Adding nonionic surfactant and antioxidant; preventing decomposition and container adsorption of prostaglandin derivative in ophthalmic solution |
| 05/20/2004 | US20040097591 Increasing testosterone levels; sexual dysfunction; kits |
| 05/20/2004 | US20040097590 Diabetes mellitus; such as 2-methyl-3-(4-(2-(5-methyl-2-thiophen-2-yl-oxazol-4-yl)-ethoxy)-phenyl)-2 -phenoxypropionic acid |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097588 High levels of trans 10, cis 12 component combined with cis 9, trans 11 component |
| 05/20/2004 | US20040097587 Utilizing tretinoin and/or isotretinoin; retinoid receptor compounds |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097584 Chlorogenic acid and an analog thereof for immune system stimulation |
| 05/20/2004 | US20040097583 Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders |
| 05/20/2004 | US20040097582 Contacting abdominal organ with a blood-flow to abdominal organ decrease preventing agent for negating or reducing decrease in blood flow in an abdominal organ which would otherwise have decreased oxygen delivery because of decreased |
| 05/20/2004 | US20040097580 For therapy and prophylaxis of diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products |
| 05/20/2004 | US20040097579 Taxane formulations |
| 05/20/2004 | US20040097578 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/20/2004 | US20040097577 Use of at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt of melatonin or melatonin analogue, in the preparation of a medicament for the treatment of ADHD in a mammal, especially a human being |
| 05/20/2004 | US20040097576 Use of tryptophane-derivatives, that are toxicated into specific toxins in body's cell by enzymes tryptophan-hydroxylase and aromatic amino acid decarboxylase of body, for simultaneous reduction and/or disruption of serotonin |
| 05/20/2004 | US20040097575 For therapy of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient; to provide neuroprotective effect to the eye of mammals |
| 05/20/2004 | US20040097573 Use of a COX-2 inhibitor and a NK-1 receptor antagonist for the manufacture of a medicament for the treatment or prevention of inflammatory disorders |
| 05/20/2004 | US20040097571 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/20/2004 | US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 05/20/2004 | US20040097569 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 05/20/2004 | US20040097568 Crystalline form of losartan potassium |
| 05/20/2004 | US20040097567 For stimulation of insulin secretion; therapy of diabetes |
| 05/20/2004 | US20040097565 For therapy of pain associated with chronic inflammation or headache associated with hypertension |
| 05/20/2004 | US20040097564 Method and compounds for treating glaucoma VI |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097562 Administering an amount of an agent effective to interact with neuronal transmission connected with pain perception |
| 05/20/2004 | US20040097561 Benzamides and related inhibitors of factor Xa |
| 05/20/2004 | US20040097557 Administering substituted cyanothiophene derivatives for therapy of type 2 diabetes mellitus in mammal |
| 05/20/2004 | US20040097556 Administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an insulin secretagogue, to a mammal |
| 05/20/2004 | US20040097555 Useful as a prophylactic or therapeutic agent of the diseases such as rheumatism, arthritis and the like, and other diseases |
| 05/20/2004 | US20040097553 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097550 For therapy of thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases |
| 05/20/2004 | US20040097549 Feeding to the animal a metered amount of a food wherein a selective cyclooxygenase- 2 inhibitor is homogeneously dispersed for therapy or prophylaxis of inflammation or an inflammation-related condition or disorder such as arthritis |
| 05/20/2004 | US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 05/20/2004 | US20040097545 Quinolinone derivatives |
| 05/20/2004 | US20040097544 Use of an inhibitor of the Na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disturbances of the central nervous system |
| 05/20/2004 | US20040097543 Use of cyclic 2,4-diphosphoclycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097538 Therapy of cardiovascular, cerebral vascular, or peripheral vascular disease in a mammal in need thereof, by providing mammal with an effective amount of a rapamycin |
| 05/20/2004 | US20040097537 6-phenylbenzonaphthyridines |
| 05/20/2004 | US20040097536 Extended release oral dosage composition |
| 05/20/2004 | US20040097534 Composition for the protection and regeneration of nerve cells containing berberine derivatives |
| 05/20/2004 | US20040097533 Useful as potassium channel blockers and antiarrhythmic drugs |
| 05/20/2004 | US20040097532 3-Substituted oxindole beta 3 agonists |
| 05/20/2004 | US20040097530 Novel heteroaryl derivatives and their use as medicaments |
| 05/20/2004 | US20040097529 Novel use of arylethene sulfonamide derivative |
| 05/20/2004 | US20040097527 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 05/20/2004 | US20040097526 Using triazolo(4,5-d)pyrimidine derivatives or a pharmaceutically acceptable salt or prodrug, in manufacture of a medicament for therapy or prevention of a disorder in which blocking of purine receptors may be beneficial |
| 05/20/2004 | US20040097525 Novel Compounds |
| 05/20/2004 | US20040097524 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 05/20/2004 | US20040097521 Clinical treatment |
| 05/20/2004 | US20040097520 Methods of use of fluoroquinolone compounds against ciprofloxacin-resistant and ciprofloxacin-sensitive pathogenic bacteria |
| 05/20/2004 | US20040097519 Novel salt and crystalline forms of (2r)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber- 5-yl)piperazin-1-yl]- 2-hydroxypropoxy}quinoline |
| 05/20/2004 | US20040097518 For use in therapy and prophylaxis |
| 05/20/2004 | US20040097515 Having reduced cardiac toxicity; for therapy of infections |
| 05/20/2004 | US20040097514 Sustained release ranolazine formulations |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097512 Antibiotic compositions for treatment of the eye, ear and nose |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |
| 05/20/2004 | US20040097507 Useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by multidrug resistance protein MRP1 |
| 05/20/2004 | US20040097506 Pyrimidine derivatives for inhibition of cell proliferation |
| 05/20/2004 | US20040097503 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/20/2004 | US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097500 Compounds and compositions for delivering active agents |
| 05/20/2004 | US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097489 2-methyl-thieno-benzodiazepine formulation |
| 05/20/2004 | US20040097488 Having less sedative effects |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097486 Administering a pharmaceutically effective amount of a formulation comprising an H1 antagonist and a safe steroid for therapy of ocular conditions in mammals selected from vernal keratoconjunctivitis, giant papillary conjunctivitis |
| 05/20/2004 | US20040097484 Once a day galantamine pharmaceutical compositions and methods of use |
| 05/20/2004 | US20040097482 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 05/20/2004 | US20040097481 For therapy of hyperbilirubinemia |
| 05/20/2004 | US20040097478 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 05/20/2004 | US20040097477 For controlling male fertility in a mammal |
| 05/20/2004 | US20040097476 Useful to treat congestive heart failure while avoiding or reducing aldosterone-antagonist-induced side effects, such as hyperkalemia |
| 05/20/2004 | US20040097474 Administering formulation comprising anti-allergy agent selected from emedastine and olopatadine and steroid selected from the group consisting of fluticasone, mometasone, budesonide and beclomethasone for therapy of allergic rhinitis |
| 05/20/2004 | US20040097473 Use of p38 inhibitors for the treatment of smoke inhalation |
| 05/20/2004 | US20040097472 Complexes of phosphate derivatives |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/20/2004 | US20040097470 Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals |
| 05/20/2004 | US20040097469 For prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 05/20/2004 | US20040097468 Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment |
| 05/20/2004 | US20040097467 Administering to individual an effective amount of an arginine silicate inositol complex for therapy of symptoms of a bone or cartilage disorder |
| 05/20/2004 | US20040097466 Treatment of a patient suffering from cell surface thrombosis disorders using enhanced absorption of arginine |
| 05/20/2004 | US20040097465 ll-12 expression controlling agents |
| 05/20/2004 | US20040097464 Mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy |
| 05/20/2004 | US20040097463 Administering to a subject in need of such treatment an amount of a formulation comprising an isolated molecule selected from the group consisting of asiatic acid and asiaticoside |
| 05/20/2004 | US20040097462 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/20/2004 | US20040097461 Methods and compositions for treating hepatitis C Virus |
| 05/20/2004 | US20040097456 Using a cytokine for prophylaxis, therapy and diagnosis of skin related growth disorders in mammals |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040097437 Sequential therapy comprising a 20(S)-camptothecin and an anthracycline |